Curaleaf has agreed to pay $100,000 to settle a class-action lawsuit over a 2021 manufacturing blunder in which the company sold CBD wellness drops in Oregon that contained THC, the psychoactive ingredient in cannabis.
Several people reported alarming symptoms after taking the drops, sold under Curaleaf’s Select brand. CBD isn’t supposed to contain significant levels of any mind-altering substance, but the drops sold last year had a jumbo dose of THC, resulting in severe reactions and confusion. Some people were driving when they suffered the effects, while others rushed to medical clinics.
Curaleaf settled ten lawsuits in January from people who reported such effects on undisclosed terms. In August, Curaleaf agreed to a $130,000 fine and 23-day suspension levied by Oregon cannabis regulators. A wrongful death case related to the CBD case was settled earlier this week on confidential terms. Two other personal injury cases are pending.
The latest settlement, filed Thursday with U.S. District Court in Portland, covers anyone else who bought the mislabeled CBD drops. An estimated 500 people will receive payments between $150 and $200 apiece, depending on how many people file claims. It does not restrict consumers from filing separate personal injury claims.
To read the complete article, go to www.oregonlive.com